$DX
DYNEX CAPITAL INC Stock $dx

$dx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000082667524000051 Filed on April 26, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$74.55M	$71.53M
YoY Change	-893.99%	131.88%
Cost Of Revenue	$74.77M	$74.72M
YoY Change	65.63%	138.65%
Gross Profit	-$219.0K	-$3.192M
YoY Change	-99.6%	590.91%
Gross Profit Margin	-0.29%	-4.46%
Selling, General & Admin	$6.642M	$10.88M
YoY Change	-7.71%	47.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$424.0K	$501.0K
YoY Change	-30.26%	-14.36%
% of Gross Profit
Operating Expenses	$7.243M	$11.30M
YoY Change	-5.1%	44.92%
Operating Profit	-$7.462M	-$14.49M
YoY Change	-88.0%	75.46%
Interest Expense	-$842.0K	$54.61M
YoY Change	-100.72%	74.43%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$8.304M	$40.12M
YoY Change	-115.28%	-196.16%
Income Tax
% Of Pretax Income
Net Earnings	-$10.23M	$38.20M
YoY Change	-119.51%	-191.55%
Net Earnings / Revenue	-13.72%	53.4%
Basic Earnings Per Share	-$0.15	$0.65
Diluted Earnings Per Share	-$0.15	$0.64
COMMON SHARES
Basic Shares Outstanding	64.16M shares	58.54M shares
Diluted Shares Outstanding	66.95M shares	59.72M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$286.1M	$295.7M
YoY Change	-4.66%	5.98%
Cash & Equivalents	$286.1M	$295.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$55.70M	$27.90M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$341.8M	$323.6M
YoY Change	5.35%	-21.37%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.193B	$5.841B
YoY Change	22.41%	77.16%
Other Assets	$123.1M	$122.6M
YoY Change	-7.17%	7.0%
Total Long-Term Assets	$6.342B	$5.981B
YoY Change	21.92%	72.94%
TOTAL ASSETS
Total Short-Term Assets	$341.8M	$323.6M
Total Long-Term Assets	$6.342B	$5.981B
Total Assets	$6.684B	$6.304B
YoY Change	20.95%	62.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$54.57M	$35.67M
YoY Change	61.47%	178.56%
Deferred Revenue
YoY Change
Short-Term Debt	$5.494B	$5.285B
YoY Change	30.76%	79.93%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.611B	$5.331B
YoY Change	32.18%	80.17%
LONG-TERM LIABILITIES
Long-Term Debt	$19.38M	$8.507M
YoY Change		-68.64%
Other Long-Term Liabilities	$7.571M	$6.088M
YoY Change	-98.11%	-78.83%
Total Long-Term Liabilities	$26.95M	$14.60M
YoY Change	-93.26%	-73.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.611B	$5.331B
Total Long-Term Liabilities	$26.95M	$14.60M
Total Liabilities	$5.638B	$5.346B
YoY Change	21.39%	77.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$506.1M	-$469.1M
YoY Change	21.4%	4.7%
Common Stock	$1.620B	$1.495B
YoY Change	18.67%	9.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.045B	$958.5M
YoY Change
Total Liabilities & Shareholders Equity	$6.684B	$6.304B
YoY Change	20.95%	62.91%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$10.23M	$38.20M
YoY Change	-119.51%	-191.55%
Depreciation, Depletion And Amortization	$424.0K	$501.0K
YoY Change	-30.26%	-14.36%
Cash From Operating Activities	$18.61M	-$17.10M
YoY Change	-40.91%	-557.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$335.3M	$232.6M
YoY Change	-72.91%	-170.01%
Cash From Investing Activities	-$335.3M	$232.6M
YoY Change	-72.91%	-170.01%
FINANCING ACTIVITIES
Cash Dividend Paid		$24.92M
YoY Change		8.57%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	307.6M	-$35.03M
YoY Change	-75.29%	-112.87%
NET CHANGE
Cash From Operating Activities	18.61M	-$17.10M
Cash From Investing Activities	-335.3M	$232.6M
Cash From Financing Activities	307.6M	-$35.03M
Net Change In Cash	-9.066M	$180.5M
YoY Change	-123.17%	-420.8%
FREE CASH FLOW
Cash From Operating Activities	$18.61M	-$17.10M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	8386000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	54361000	usd
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	27899000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	28727000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	9324000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	9850000	usd
CY2024Q1	us-gaap	Assets Assets	6304497000	usd
CY2023Q4	us-gaap	Assets Assets	6369750000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5284708000	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5381104000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1314000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2024Q1	dx	Cash Collateral Posted By Counterparties CashCollateralPostedByCounterparties	8507000	usd
CY2023Q4	dx	Cash Collateral Posted By Counterparties CashCollateralPostedByCounterparties	46001000	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	35672000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	53194000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10990000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10320000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	4774000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	8396000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	5345965000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5499015000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4460000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4460000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4460000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4460000	shares
CY2024Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	111500000	usd
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	111500000	usd
CY2024Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	107843000	usd
CY2023Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	107843000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64160931	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64160931	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57038247	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57038247	shares
CY2024Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	641000	usd
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	570000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1494893000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1404431000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-175770000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-158502000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-469075000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-483607000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	958532000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	870735000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6304497000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6369750000	usd
CY2024Q1	us-gaap	Interest Income Operating InterestIncomeOperating	71525000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	30846000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	74717000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	31308000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3192000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-462000	usd
CY2024Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-23315000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-70024000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	57120000	usd
CY2024Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	124635000	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-67267000	usd
CY2024Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	54611000	usd
CY2023Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-33462000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7177000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3750000	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3703000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3622000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-421000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-426000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	11301000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	7798000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	40118000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-41722000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1923000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1923000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	38195000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43645000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17268000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14793000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-17268000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	14793000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20927000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28852000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59008316	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53823866	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59717332	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53823866	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.81
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	870735000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	86806000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	510000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3760000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	527000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	16000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	40118000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1923000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	23663000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-17268000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	958532000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	901328000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2771000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	360000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	650000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	276000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	16000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-41722000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1923000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	21137000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	14793000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	854828000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	40118000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-41722000	usd
CY2024Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	-23315000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-70024000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	57120000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	124635000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-67267000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14059000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	19642000	usd
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	501000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	585000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4270000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1010000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-828000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1974000	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-17522000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-3644000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4747000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	3622000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17104000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3737000	usd
CY2024Q1	us-gaap	Payments To Acquire Trading Securities Heldforinvestment PaymentsToAcquireTradingSecuritiesHeldforinvestment	0	usd
CY2023Q1	us-gaap	Payments To Acquire Trading Securities Heldforinvestment PaymentsToAcquireTradingSecuritiesHeldforinvestment	310352000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment	78131000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment	30233000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	18874000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	22318000	usd
CY2024Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	307000	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	279000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-172784000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	101425000	usd
CY2024Q1	us-gaap	Increase Decrease Cash Collateral From Counterparties IncreaseDecreaseCashCollateralFromCounterparties	-37494000	usd
CY2023Q1	us-gaap	Increase Decrease Cash Collateral From Counterparties IncreaseDecreaseCashCollateralFromCounterparties	26690000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	232602000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-332257000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	12273321000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	5428877000	usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	12369717000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	5136158000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	86806000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2771000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	527000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	276000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	24916000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	22949000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35033000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	272265000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	180465000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-56255000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	237864000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	449877000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418329000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	393622000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	92239000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	34952000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dynex Capital, Inc. (the “Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company is an internally managed mortgage real estate investment trust, or mortgage REIT, which primarily earns income from investing on a leveraged basis in Agency mortgage-backed securities (“Agency MBS”) and in to-be-announced securities (“TBAs” or “TBA securities”). Agency MBS have a guaranty of principal and interest payments by a U.S. government-sponsored entity (“GSE”) such as Fannie Mae and Freddie Mac, which are in conservatorship and are currently supported by a senior preferred stock purchase agreement from the U.S. Treasury. As of March 31, 2024, the majority of the Company’s Agency MBS are secured by residential real property (“Agency RMBS”). The remainder of the Company’s investments are in Agency commercial MBS (“Agency CMBS”) and in both Agency and non-Agency CMBS interest-only (“CMBS IO”). Non-Agency MBS do not have a GSE guaranty of principal or interest payments.</span></div>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, amortization of premiums and discounts and fair value measurements of its investments, including TBA securities accounted for as derivative instruments. These items are discussed further below within this note to the consolidated financial statements. The Company believes the estimates and assumptions underlying the consolidated financial statements included herein are reasonable and supportable based on the information available as of March 31, 2024.
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	295715000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	122614000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418329000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2300000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	96571	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59008316	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53823866	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59717332	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53823866	shares
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	38195000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43645000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.81
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	270106	shares
CY2024Q1	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	6046940000	usd
CY2024Q1	dx	Debt Securities Trading And Available For Sale Amortized Cost DebtSecuritiesTradingAndAvailableForSaleAmortizedCost	6172124000	usd
CY2024Q1	us-gaap	Debt Securities Trading And Available For Sale DebtSecuritiesTradingAndAvailableForSale	5840559000	usd
CY2023Q4	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	6143945000	usd
CY2023Q4	dx	Debt Securities Trading And Available For Sale Amortized Cost DebtSecuritiesTradingAndAvailableForSaleAmortizedCost	6283185000	usd
CY2023Q4	us-gaap	Debt Securities Trading And Available For Sale DebtSecuritiesTradingAndAvailableForSale	6038948000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1099142000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1505000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	177275000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	923372000	usd
CY2024Q1	us-gaap	Trading Securities Debt Amortized Cost TradingSecuritiesDebtAmortizedCost	5072982000	usd
CY2024Q1	dx	Gross Unrealized Gain Investment Fair Value Option GrossUnrealizedGainInvestmentFairValueOption	22675000	usd
CY2024Q1	dx	Gross Unrealized Loss Investment Fair Value Option GrossUnrealizedLossInvestmentFairValueOption	178470000	usd
CY2024Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	4917187000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1131769000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1324000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	159826000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	973267000	usd
CY2023Q4	us-gaap	Trading Securities Debt Amortized Cost TradingSecuritiesDebtAmortizedCost	5151416000	usd
CY2023Q4	dx	Gross Unrealized Gain Investment Fair Value Option GrossUnrealizedGainInvestmentFairValueOption	48461000	usd
CY2023Q4	dx	Gross Unrealized Loss Investment Fair Value Option GrossUnrealizedLossInvestmentFairValueOption	134196000	usd
CY2023Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5065681000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-70024000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	57120000	usd
CY2024Q1	us-gaap	Debt Securities Trading Realized Loss DebtSecuritiesTradingRealizedLoss	0	usd
CY2023Q1	us-gaap	Debt Securities Trading Realized Loss DebtSecuritiesTradingRealizedLoss	23315000	usd
CY2024Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-23315000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5284708000	usd
CY2024Q1	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0546
CY2024Q1	us-gaap	Transfers Accounted For As Secured Borrowings Assets Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssetsCarryingAmount	5570076000	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5381104000	usd
CY2023Q4	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0559
CY2023Q4	us-gaap	Transfers Accounted For As Secured Borrowings Assets Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssetsCarryingAmount	5880747000	usd
CY2024Q1	dx	Number Of Counterparties Borrowings Outstanding NumberOfCounterpartiesBorrowingsOutstanding	28	counterparty
CY2024Q1	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	11500000	usd
CY2024Q1	us-gaap	Collateral Securities Repledged Delivered Or Used CollateralSecuritiesRepledgedDeliveredOrUsed	0	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5284708000	usd
CY2024Q1	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0546
CY2024Q1	dx	Originaltermtomaturity Originaltermtomaturity	76
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5381104000	usd
CY2023Q4	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0559
CY2023Q4	dx	Originaltermtomaturity Originaltermtomaturity	89
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	35700000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	53200000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	5284708000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5284708000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	5284708000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	5381104000	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5381104000	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	5381104000	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2024Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	124635000	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-67267000	usd
CY2024Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	8386000	usd
CY2023Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	54361000	usd
CY2024Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	1314000	usd
CY2023Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	0	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	8386000	usd
CY2024Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	8386000	usd
CY2024Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	1144000	usd
CY2024Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	6774000	usd
CY2024Q1	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	468000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	54361000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	54361000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	44153000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	10208000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1314000	usd
CY2024Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1314000	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1144000	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	170000	usd
CY2024Q1	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2024Q1	dx	Loans Held For Investment Fair Value Option Measurement Input LoansHeldForInvestmentFairValueOptionMeasurementInput	0.10
CY2024Q1	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	400000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4300000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1000000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	7855000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000826675-24-000051-index-headers.html	Edgar Link	pending
0000826675-24-000051-index.html	Edgar Link	pending
0000826675-24-000051.txt	Edgar Link	pending
0000826675-24-000051-xbrl.zip	Edgar Link	pending
dx-20240331.htm	Edgar Link	pending
dx-20240331.xsd	Edgar Link	pending
dx-20240331_g1.jpg	Edgar Link	pending
dx-20240331_g2.jpg	Edgar Link	pending
dx-20240331_g3.jpg	Edgar Link	pending
ex10411formofpsuagreement2.htm	Edgar Link	pending
ex10412formofrsuagreement2.htm	Edgar Link	pending
exhibit10413formofrsuagree.htm	Edgar Link	pending
exhibit10414formofpsuagree.htm	Edgar Link	pending
exhibit311ceocertification.htm	Edgar Link	pending
exhibit312cfocertification.htm	Edgar Link	pending
exhibit321soxcertification.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
dx-20240331_cal.xml	Edgar Link	unprocessable
dx-20240331_def.xml	Edgar Link	unprocessable
dx-20240331_lab.xml	Edgar Link	unprocessable
dx-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dx-20240331_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DX
DYNEX CAPITAL INC Stock $dx

2024 Q2 Form 10-Q Financial Statement

#000082667524000051 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX DYNEX CAPITAL INC Stock $dx

2024 Q2 Form 10-Q Financial Statement

#000082667524000051 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX
DYNEX CAPITAL INC Stock $dx